Paper9869576
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
Zhou XJ and 8 others. Antimicrob Agents Chemother, 1999. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Papers, record 9869576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9869576
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
- PubMed
- Publication types
- Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Didanosine | Major topic |
| HIV Infections | Major topic |
| Nevirapine | Major topic |
| Zidovudine | Major topic |
| Acquired Immunodeficiency Syndrome | |
| Adolescent | |
| Adult | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Models, Biological |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00000770 | A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine | Background |
Source ClinicalTrials.gov
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8086138 | Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients. | AIDS | 1994 | https://conductscience.org/library/papers/8086138 | PubMed |
| 2 | 1416828 | Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1416828 | PubMed |
| 3 | 7861025 | Clinical pharmacokinetics of nucleoside antiretroviral agents. | J Infect Dis | 1995 | https://conductscience.org/library/papers/7861025 | PubMed |
| 4 | 7533197 | High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. | J Infect Dis | 1995 | https://conductscience.org/library/papers/7533197 | PubMed |
| 5 | 7888117 | Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions. | AIDS | 1994 | https://conductscience.org/library/papers/7888117 | PubMed |
| 6 | 7542804 | Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. | Science | 1995 | https://conductscience.org/library/papers/7542804 | PubMed |
| 7 | 8537676 | Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8537676 | PubMed |
| 8 | 8568296 | Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8568296 | PubMed |
| 9 | 8595509 | Studies of zidovudine in combination with didanosine and zalcitabine. | J Acquir Immune Defic Syndr Hum Retrovirol | 1995 | https://conductscience.org/library/papers/8595509 | PubMed |
| 10 | 8648207 | Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8648207 | PubMed |
| 11 | 8633815 | Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. | Ann Intern Med | 1996 | https://conductscience.org/library/papers/8633815 | PubMed |
| 12 | 8656777 | Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development. | Med Res Rev | 1996 | https://conductscience.org/library/papers/8656777 | PubMed |
| 13 | 8924237 | Selection in vitro of an HIV-1 variant resistant to both lamivudine (3TC) and zidovudine. | AIDS | 1996 | https://conductscience.org/library/papers/8924237 | PubMed |
| 14 | 8656502 | Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group. | JAMA | 1996 | https://conductscience.org/library/papers/8656502 | PubMed |
| 15 | 8709686 | Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee. | Lancet | 1996 | https://conductscience.org/library/papers/8709686 | PubMed |
| 16 | 8780817 | Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy. | AIDS | 1996 | https://conductscience.org/library/papers/8780817 | PubMed |
| 17 | 8835201 | Comparative pharmacokinetics of zidovudine and its toxic catabolite 3'-amino-3'-deoxythymidine in HIV-infected patients. | AIDS Res Hum Retroviruses | 1996 | https://conductscience.org/library/papers/8835201 | PubMed |
| 18 | 8853730 | Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. | AIDS | 1996 | https://conductscience.org/library/papers/8853730 | PubMed |
| 19 | 8983858 | Clinical pharmacokinetics of zidovudine. An update. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8983858 | PubMed |
| 20 | 8990341 | HIV-1 protease inhibitors. A review for clinicians. | JAMA | 1997 | https://conductscience.org/library/papers/8990341 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42549359 | The relationship between plasma favipiravir concentrations and clinical outcomes in COVID-19. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42549359 | PubMed |
| 41155646 | Resensitizing the Untreatable: Zidovudine and Polymyxin Combinations to Combat Pan-Drug-Resistant Klebsiella pneumoniae. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155646 | PubMed |
| 39542985 | Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005. | Clin Pharmacokinet | 2024 | https://conductscience.org/library/papers/39542985 | PubMed |
| 33241266 | Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/33241266 | PubMed |
| 30670431 | Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30670431 | PubMed |
| 29899984 | Clinical and genetic determinants of nevirapine plasma trough concentration. | SAGE Open Med | 2018 | https://conductscience.org/library/papers/29899984 | PubMed |
| 27707991 | Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children. | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/27707991 | PubMed |
| 27528996 | Evaluation of antiretroviral therapy results in Blantyre, Malawi. | Malawi Med J | 2005 | https://conductscience.org/library/papers/27528996 | PubMed |
| 25064169 | Population pharmacokinetic model to analyze nevirapine multiple-peaks profile after a single oral dose. | J Pharmacokinet Pharmacodyn | 2014 | https://conductscience.org/library/papers/25064169 | PubMed |
| 24088395 | Caring for women living with HIV: gaps in the evidence. | J Int AIDS Soc | 2013 | https://conductscience.org/library/papers/24088395 | PubMed |
| 23877688 | Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23877688 | PubMed |
| 23514375 | Clinical pharmacokinetics of antiretroviral drugs in older persons. | Expert Opin Drug Metab Toxicol | 2013 | https://conductscience.org/library/papers/23514375 | PubMed |
| 23459477 | Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23459477 | PubMed |
| 22869579 | Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22869579 | PubMed |
| 22301417 | Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. | AIDS | 2012 | https://conductscience.org/library/papers/22301417 | PubMed |
| 22300396 | Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics. | Br J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22300396 | PubMed |
| 21233689 | Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir. | Ther Drug Monit | 2011 | https://conductscience.org/library/papers/21233689 | PubMed |
| 20696882 | Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20696882 | PubMed |
| 20038617 | Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20038617 | PubMed |
| 19493344 | Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. | BMC Infect Dis | 2009 | https://conductscience.org/library/papers/19493344 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9869576
GET https://conductscience.org/api/papers/v1/9869576/references?page=2